India Rejects Wockhardt Appeals For Price Reviews For Three Drugs
This article was originally published in PharmAsia News
Executive Summary
Wockhardt has been turned down in separate appeals for a review of the price caps set on three of its drugs, including an insulin injection, povidone iodine ointment and an antiseptic wound treatment.